The biology of glucagon and the consequences of hyperglucagonemia

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt


The proglucagon-derived peptide hormone, glucagon, comprises 29 amino acids. Its secretion from the pancreatic α cells is regulated by several factors. Glucagon increases blood glucose levels through gluconeogenesis and glycogenolysis. Elevated plasma concentrations of glucagon, hyperglucagonemia, may contribute to diabetes. However, hyperglucagonemia is also observed in other clinical conditions than diabetes, including nonalcoholic fatty liver disease, glucagon-producing tumors and after gastric bypass surgery. Here, we review the current literature on hyperglucagonemia in disease with a particular focus on diabetes, and finally speculate that the primary physiological importance of glucagon may not reside in glucose homeostasis but in regulation of amino acid metabolism exerted via a hitherto unrecognized hepato-pancreatic feedback loop.

TidsskriftBiomarkers in Medicine
Udgave nummer11
Sider (fra-til)1141-1151
Antal sider11
StatusUdgivet - 9 sep. 2016

Antal downloads er baseret på statistik fra Google Scholar og

Ingen data tilgængelig

ID: 165941600